Exploiting a conjugative endogenous CRISPR-Cas3 system to tackle multidrug-resistant Klebsiella pneumoniae
2023 · EBioMedicine · 40 citations
https://doi.org/10.1016/j.ebiom.2023.104445
D
Dongxing Tian
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
42
Papers
700
Citations
14
h-index
17
i10-index
Dongxing Tian is an academic researcher from Shandong University of Traditional Chinese Medicine. The author has contributed to research in topics: Antibiotic Resistance in Bacteria & CRISPR and Genetic Engineering & Mycobacterium research and diagnosis. The author has an h-index of 14, co-authored 36 publications.
ORCID: 0000-0002-7301-7116Papers by this author
worksArachidonic acid released by PIK3CA mutant tumor cells triggers malignant transformation of colonic epithelium by inducing chromatin remodeling
2024 · Cell Reports Medicine · 17 citations
https://doi.org/10.1016/j.xcrm.2024.101510
MT1G induces lipid droplet accumulation through modulation of H3K14 trimethylation accelerating clear cell renal cell carcinoma progression
2024 · British Journal of Cancer · 12 citations
https://doi.org/10.1038/s41416-024-02747-y
Involvement of Tn3 transposon in formation and transmission of hypervirulent and carbapenem-resistant <i>Klebsiella pneumoniae</i>
2023 · Microbiology Spectrum · 9 citations
https://doi.org/10.1128/spectrum.03038-23
Dissemination of clinical Escherichia coli strains harboring mcr-1, blaNDM−7 and siderophore-producing plasmids in a Chinese hospital
2024 · Antimicrobial Resistance and Infection Control · 8 citations
https://doi.org/10.1186/s13756-024-01423-3
The type I-E CRISPR-Cas system influences the acquisition of <i>bla</i> <sub>KPC</sub>-IncF plasmid in <i>Klebsiella pneumonia</i>
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.12340724.v10
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat